In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions

Diagn Microbiol Infect Dis. 2015 Aug;82(4):318-25. doi: 10.1016/j.diagmicrobio.2015.01.006. Epub 2015 Jan 23.

Abstract

The impact of physicochemical conditions observed in cystic fibrosis (CF) lung on colistin activity against both planktonic and biofilm P. aeruginosa cells was evaluated. MIC, minimum bactericidal concentration (MBC), and minimum biofilm eradication concentration (MBEC) values were assessed against 12 CF strains both under "CF-like" (anaerobiosis, pH6.4) and "standard" (aerobiosis, pH7.4) conditions. The activity of colistin was significantly higher under "CF-like" conditions compared to "standard" ones, both against planktonic (MIC90: 1 and 4 μg/mL, respectively) and biofilm (MBEC90: 512 and 1.024 μg/mL, respectively) cells, as confirmed by scanning electron microscopy. Improved activity was not related to biofilm matrix amount. It may be necessary to adequately "rethink" the protocols used for in vitro assessment of colistin activity, by considering physicochemical and microbiological features in the CF lung at the site of infection. This could provide a more favorable therapeutic index, rationale for administration of lower doses, probably resulting in reduced toxicity and emergence of resistant clones.

Keywords: Biofilm; Colistin; Cystic fibrosis; In vitro antimicrobial susceptibility assay; Lung infection; Pseudomonas aeruginosa.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anaerobiosis
  • Anti-Bacterial Agents / pharmacology*
  • Biofilms / drug effects*
  • Colistin / pharmacology*
  • Culture Media / chemistry*
  • Cystic Fibrosis / complications
  • Humans
  • Hydrogen-Ion Concentration
  • Microbial Sensitivity Tests / methods*
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / physiology

Substances

  • Anti-Bacterial Agents
  • Culture Media
  • Colistin